Targeted gene therapies: tools, applications, optimization
Olivier Humbert1, Luther Davis, Nancy Maizels
1Departments of Immunology and Biochemistry, University of Washington School of Medicine, Seattle, WA 98195, USA.
Abstract:
Many devastating human diseases are caused by mutations in a single gene that prevent a somatic cell from carrying out its essential functions, or by genetic changes acquired as a result of infectious disease or in the course of cell transformation. Targeted gene therapies have emerged as potential strategies for treatment of such diseases. These therapies depend upon rare-cutting endonucleases to cleave at specific sites in or near disease genes. Targeted gene correction provides a template for homology-directed repair, enabling the cell's own repair pathways to erase the mutation and replace it with the correct sequence. Targeted gene disruption ablates the disease gene, disabling its function. Gene targeting can also promote other kinds of genome engineering, including mutation, insertion, or gene deletion. Targeted gene therapies present significant advantages compared to approaches to gene therapy that depend upon delivery of stably expressing transgenes. Recent progress has been fueled by advances in nuclease discovery and design, and by new strategies that maximize efficiency of targeting and minimize off-target damage. Future progress will build on deeper mechanistic understanding of critical factors and pathways.
Insights
Targeted gene therapies utilize rare-cutting endonucleases to correct or disable disease-causing genes. Advances in nuclease technology enhance precision and efficiency for treating genetic diseases.
Area of Science:
- Molecular Biology
- Genetics
- Biotechnology
Background:
- Many diseases stem from single-gene mutations or acquired genetic alterations.
- Targeted gene therapies offer a promising treatment strategy for these conditions.
- Current therapies often rely on rare-cutting endonucleases for precise DNA modification.
Purpose of the Study:
- To review the principles and advancements in targeted gene therapies.
- To highlight the advantages of gene targeting over traditional gene therapy methods.
- To discuss future directions and challenges in the field.
Main Methods:
- Gene targeting using rare-cutting endonucleases.
- Homology-directed repair for gene correction.
- Gene disruption for ablating disease genes.
- Genome engineering techniques including mutation, insertion, and deletion.
Main Results:
- Targeted gene therapies enable precise correction or disruption of disease-associated genes.
- Gene targeting offers advantages over transgene-based gene therapy approaches.
- Recent progress is driven by nuclease innovation and improved targeting strategies.
Conclusions:
- Targeted gene therapies hold significant potential for treating a range of human diseases.
- Continued advancements in nuclease technology and mechanistic understanding are crucial for future progress.
- Minimizing off-target effects remains a key focus for safe and effective gene therapy.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Gene Therapy
Gene Therapy
Pharmacogenomics: Identification of New Drug Targets
Microorganisms in Medicine and Therapeutics

